Yokota M, Tsunekawa A, Miyahara T, Kamihara S, Kitamura J, Noda S, Koide M, Tsuzuki M, Sotobata I
Am J Cardiol. 1986 Jul 1;58(1):53-8. doi: 10.1016/0002-9149(86)90240-7.
Hemodynamic effects of isosorbide-5-mononitrate (ISMN) were studied in 14 patients with effort angina pectoris. Hemodynamic and echocardiographic data were obtained by angina-limited supine multistage bicycle ergometer exercise testing before and 120 minutes after single oral administration of 20 mg of ISMN. Compared with control exercise testing, the ST segment at peak exercise showed less depression after administration of ISMN (p less than 0.001). At rest, systolic and diastolic blood pressure decreased significantly after administration of ISMN (p less than 0.001 and p less than 0.01, respectively). At rest and at peak exercise, pulmonary artery wedge pressure (both p less than 0.001), left atrial volume (both p less than 0.001) and left ventricular end-diastolic volume (both p less than 0.05) decreased, whereas cardiac index, pressure-rate product and systemic vascular resistance did not change significantly after administration of ISMN. Average time to peak plasma ISMN concentration was 90 minutes and average peak plasma concentration was 460 ng/ml with an elimination half-life of 7 hours. These data suggest that the main mechanism of the antianginal action of ISMN is a reduction in left ventricular preload followed by diminution of myocardial oxygen requirements.
对14例劳力性心绞痛患者研究了单硝酸异山梨酯(ISMN)的血流动力学效应。在单次口服20mg ISMN前及服药后120分钟,通过心绞痛限制下的仰卧位多级自行车测力计运动试验获取血流动力学和超声心动图数据。与对照运动试验相比,服用ISMN后运动高峰时的ST段压低减轻(p<0.001)。静息时,服用ISMN后收缩压和舒张压显著降低(分别为p<0.001和p<0.01)。静息和运动高峰时,肺动脉楔压(均为p<0.001)、左房容积(均为p<0.001)和左室舒张末期容积(均为p<0.05)均降低,而服用ISMN后心脏指数、压力-心率乘积和体循环血管阻力无显著变化。血浆ISMN浓度达峰的平均时间为90分钟,平均血浆峰浓度为460ng/ml,消除半衰期为7小时。这些数据提示,ISMN抗心绞痛作用的主要机制是降低左室前负荷,随后减少心肌需氧量。